Home › Funds › Bain Capital Life Sciences Investors, LLC › VNDA

Bain Capital Life Sciences Investors, LLC position in VNDA

VANDA PHARMACEUTICALS INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 6,728,970 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$134.2M, representing 9.24% of its reported portfolio and ranking #3 among its reported holdings. Bain Capital Life Sciences Investors, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)6.73M sh
Reported value held$134.18M
Portfolio Weight9.24%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's VNDA position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in VNDA in Q3 2026 at 6,728,970 shares (US$134.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 6.73M $134.18M New

About VNDA and 13F data

VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in VNDA — the largest reported positions include TCG Crossover Management, LLC (US$82.1M), Siren, L.L.C. (US$38.4M), EcoR1 Capital, LLC (US$22.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VNDA

All VNDA fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held VNDA?

Bain Capital Life Sciences Investors, LLC has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Bain Capital Life Sciences Investors, LLC's current position in VNDA?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 6.73M shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $134.18M, representing 9.24% of its reported portfolio and ranking #3.

Has Bain Capital Life Sciences Investors, LLC been buying or selling VNDA?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC newly opened its position in VNDA.

Which other funds hold VNDA?

Other major institutional holders of VNDA include TCG Crossover Management, LLC, Siren, L.L.C., EcoR1 Capital, LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.